[Immunosuppressive treatment for heterologous cardiac transplantation. Its possible efficacy in a rejection crisis].
D000818:Animals; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D001623:Betamethasone / Q000009:adverse effects / Q000627:therapeutic use; D003907:Dexamethasone / Q000009:adverse effects / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use*; D006084:Graft Rejection; D016027:Heart Transplantation; D006648:Histocompatibility; D006736:Horses; D006801:Humans; D006854:Hydrocortisone / Q000009:adverse effects / Q000627:therapeutic use; D007538:Isoniazid / Q000627:therapeutic use; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use; D012712:Serum Globulins / Q000009:adverse effects / Q000627:therapeutic use*; D012756:Sheep; D013921:Thrombocytopenia / Q000139:chemically induced; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D005938:Glucocorticoids; D012712:Serum Globulins; D003907:Dexamethasone; D001623:Betamethasone; D011239:Prednisolone; D001379:Azathioprine; D007538:Isoniazid; D006854:Hydrocortisone
Traitement immuno-dépresseur pour transplantation cardiaque allogénique. Son efficacité probable sur une crise de rejet.